Literature DB >> 11679587

Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110.

Hyun Kang1, Helga Schneider, Christopher E Rudd.   

Abstract

Phosphatidylinositol 3-kinase (PI3K) is a key regulator of a variety of cellular functions from cytoskeletal organization, vesicular trafficking, and cell proliferation to apoptosis. The enzyme complex is comprised of an 85-kDa adaptor (p85) coupled to a 110-kDa catalytic subunit (p110). While the function of PI3K has been largely attributed to the generation of D-3 lipids, an unanswered question has been whether p85 with a number of motifs (SH2, SH3, BcR homology (BH) region) can generate independent intracellular signals. In this study, we demonstrate that p85 lacking p110 (Deltap85) can activate NFAT transcription in T-cell hybridomas and normal splenocytes. This up-regulatory effect was unaffected by inhibition of PI 3-kinase, and cooperated specifically with Rac1, but not related family members. Stimulation correlated with Rac1 binding and was lost with the deletion of the BH domain. Lastly, the CD28-Deltap85 chimera also cooperated with TcR/CD3 to provide co-signals that enhanced IL-2 transcription. Our findings identify for the first time p85 as an adaptor that operates independently of the classic PI 3-kinase catalytic pathway and further shows that this pathway can provide co-signals in the regulation of T-cell function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679587     DOI: 10.1074/jbc.M107648200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

2.  T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

Authors:  Jonathan A Deane; Michael G Kharas; Jean S Oak; Linda N Stiles; Ji Luo; Travis I Moore; Hong Ji; Christian Rommel; Lewis C Cantley; Thomas E Lane; David A Fruman
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

3.  A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy.

Authors:  Takaaki Senbonmatsu; Takako Saito; Erwin J Landon; Otsu Watanabe; Edward Price; Richard L Roberts; Hans Imboden; Trinita G Fitzgerald; F Andrew Gaffney; Tadashi Inagami
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

4.  The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.

Authors:  Cullen M Taniguchi; José O Aleman; Kohjiro Ueki; Ji Luo; Tomoichiro Asano; Hideaki Kaneto; Gregory Stephanopoulos; Lewis C Cantley; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

5.  The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells.

Authors:  Jean S Oak; Jing Chen; Raechel Q Peralta; Jonathan A Deane; David A Fruman
Journal:  Autoimmunity       Date:  2009-08       Impact factor: 2.815

6.  Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling.

Authors:  Kristy L Houck; Todd E Fox; Lakshman Sandirasegarane; Mark Kester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

7.  Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding.

Authors:  Annat F Ikin; Mirsada Causevic; Steve Pedrini; Lyndsey S Benson; Joseph D Buxbaum; Toshiharu Suzuki; Simon Lovestone; Shigeki Higashiyama; Tomas Mustelin; Robert D Burgoyne; Sam Gandy
Journal:  Mol Neurodegener       Date:  2007-12-09       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.